OBJECTIVES: To assess the association between male circumcision, insertive anal sex practices, and HIV acquisition in a cohort of MSM. METHODS: Data were from 1824 HSV-2-seropositive, HIV-seronegative MSM, 1362 (75%) from Peru and 462 (25%) from the US, who participated in a randomized placebo-controlled trial of HSV-2 suppression for HIV prevention (HPTN 039). Circumcision status was determined by examination at enrollment. HIV testing was done every 3 months for up to 18 months. Partner-specific sexual behavior for up to the last three partners during the previous 3 months was analyzed. RESULTS: There was no significant association between male circumcision and HIV acquisition in univariate analysis [relative risk (RR) = 0.84, 95% confidence interval (CI) 0.50-1.42]. In a prespecified multivariate analysis that assumed a linear relationship between the proportion of insertive acts and effect of circumcision on HIV acquisition, the interaction between circumcision and proportion of insertive acts was not significant (P = 0.11). In an exploratory analysis that categorized behavior with recent partners by proportion of insertive acts (<60 or ≥60% insertive acts), circumcision was associated with a nonstatistically significant 69% reduction in the risk of HIV acquisition (RR = 0.31, 95% CI 0.06-1.51) among men who reported at least 60% of insertive acts with recent male partners. CONCLUSION: Circumcision does not have a significant protective effect against HIV acquisition among MSM from Peru and US, although there may be reduced risk for men who are primarily insertive with their male partners. This association needs to be investigated across diverse cohorts of MSM.
RCT Entities:
OBJECTIVES: To assess the association between male circumcision, insertive anal sex practices, and HIV acquisition in a cohort of MSM. METHODS: Data were from 1824 HSV-2-seropositive, HIV-seronegative MSM, 1362 (75%) from Peru and 462 (25%) from the US, who participated in a randomized placebo-controlled trial of HSV-2 suppression for HIV prevention (HPTN 039). Circumcision status was determined by examination at enrollment. HIV testing was done every 3 months for up to 18 months. Partner-specific sexual behavior for up to the last three partners during the previous 3 months was analyzed. RESULTS: There was no significant association between male circumcision and HIV acquisition in univariate analysis [relative risk (RR) = 0.84, 95% confidence interval (CI) 0.50-1.42]. In a prespecified multivariate analysis that assumed a linear relationship between the proportion of insertive acts and effect of circumcision on HIV acquisition, the interaction between circumcision and proportion of insertive acts was not significant (P = 0.11). In an exploratory analysis that categorized behavior with recent partners by proportion of insertive acts (<60 or ≥60% insertive acts), circumcision was associated with a nonstatistically significant 69% reduction in the risk of HIV acquisition (RR = 0.31, 95% CI 0.06-1.51) among men who reported at least 60% of insertive acts with recent male partners. CONCLUSION: Circumcision does not have a significant protective effect against HIV acquisition among MSM from Peru and US, although there may be reduced risk for men who are primarily insertive with their male partners. This association needs to be investigated across diverse cohorts of MSM.
Authors: Jorge Sanchez; Javier R Lama; Jesus Peinado; Andres Paredes; Aldo Lucchetti; Kevin Russell; Tadeusz Kochel; Jose L Sebastian Journal: J Acquir Immune Defic Syndr Date: 2009-05-01 Impact factor: 3.731
Authors: Connie Celum; Anna Wald; James Hughes; Jorge Sanchez; Stewart Reid; Sinead Delany-Moretlwe; Frances Cowan; Martin Casapia; Abner Ortiz; Jonathan Fuchs; Susan Buchbinder; Beryl Koblin; Sheryl Zwerski; Scott Rose; Jing Wang; Lawrence Corey Journal: Lancet Date: 2008-06-21 Impact factor: 79.321
Authors: David J Templeton; Fengyi Jin; Limin Mao; Garrett P Prestage; Basil Donovan; John Imrie; Susan Kippax; John M Kaldor; Andrew E Grulich Journal: AIDS Date: 2009-11-13 Impact factor: 4.177
Authors: Ramon J Soto; Annette E Ghee; Cesar A Nunez; Ruben Mayorga; Kenneth A Tapia; Sabina G Astete; James P Hughes; Anne L Buffardi; Sarah E Holte; King K Holmes Journal: J Acquir Immune Defic Syndr Date: 2007-09-01 Impact factor: 3.731
Authors: Francisco I Bastos; Carlos Cáceres; Jane Galvão; Maria Amélia Veras; Euclides Ayres Castilho Journal: Int J Epidemiol Date: 2008-08 Impact factor: 7.196
Authors: Ronald H Gray; David Serwadda; Aaron A R Tobian; Michael Z Chen; Frederick Makumbi; Tara Suntoke; Godfrey Kigozi; Fred Nalugoda; Boaz Iga; Thomas C Quinn; Lawrence H Moulton; Oliver Laeyendecker; Steven J Reynolds; Xiangrong Kong; Maria J Wawer Journal: PLoS Med Date: 2009-11-24 Impact factor: 11.069
Authors: Sten H Vermund; José A Tique; Holly M Cassell; Megan E Pask; Philip J Ciampa; Carolyn M Audet Journal: J Acquir Immune Defic Syndr Date: 2013-06-01 Impact factor: 3.731
Authors: Felisa A Gonzales; Maria Cecilia Zea; Carol A Reisen; Fernanda T Bianchi; Carlos Fabian Betancourt Rodríguez; Marcela Aguilar Pardo; Paul J Poppen Journal: Cult Health Sex Date: 2012-08-23
Authors: Han-Zhu Qian; Yuhua Ruan; Yu Liu; Douglas F Milam; Hans M L Spiegel; Lu Yin; Dongliang Li; Bryan E Shepherd; Yiming Shao; Sten H Vermund Journal: J Acquir Immune Defic Syndr Date: 2016-04-01 Impact factor: 3.731
Authors: Stefan D Baral; Andrea Wirtz; Frangiscos Sifakis; Benjamin Johns; Damian Walker; Chris Beyrer Journal: Public Health Rep Date: 2012 Nov-Dec Impact factor: 2.792
Authors: Jeanne M Marrazzo; Carlos del Rio; David R Holtgrave; Myron S Cohen; Seth C Kalichman; Kenneth H Mayer; Julio S G Montaner; Darrell P Wheeler; Robert M Grant; Beatriz Grinsztejn; N Kumarasamy; Steven Shoptaw; Rochelle P Walensky; Francois Dabis; Jeremy Sugarman; Constance A Benson Journal: JAMA Date: 2014 Jul 23-30 Impact factor: 56.272